[1]
“Impressive and Prolonged Response with Lenvatinib in a Highly Pretreated Patient with Metastatic Clear Cell Renal Cancer: A Case Report”, jkcvhl, vol. 11, no. 2, pp. 1–6, Apr. 2024, doi: 10.15586/jkcvhl.v11i2.317.